Scarica l'app Stockscreener
6.69
1.62%
-0.11
Dopo l'orario di chiusura:
6.69
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$6.80
Aprire:
$6.51
Volume 24 ore:
1.17M
Relative Volume:
0.89
Capitalizzazione di mercato:
$646.45M
Reddito:
$47.56M
Utile/perdita netta:
$-156.83M
Rapporto P/E:
-3.6557
EPS:
-1.83
Flusso di cassa netto:
$-127.98M
1 W Prestazione:
-14.56%
1M Prestazione:
-15.42%
6M Prestazione:
-47.65%
1 anno Prestazione:
-59.92%
Intervallo 1D:
$6.39
$6.99
Intervallo di 1 settimana:
$6.39
$7.7508
Portata 52W:
$6.39
$19.09
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
6.69 | 646.45M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
149.10 | 67.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.38 | 46.50B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.27 | 44.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.94 | 15.97B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
291.72 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Sold by Commonwealth Equity Services LLC - Defense World
Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times
When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News
Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st
Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Analyzing Avadel Pharmaceuticals plc (AVDL) After Recent Trading Activity - Knox Daily
HC Wainwright Issues Pessimistic Outlook for AVDL Earnings - Defense World
Avadel Pharmaceuticals Announces Executive Equity Grants By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals Announces Executive Equity Grants - Investing.com
Avadel Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire
Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire
What is HC Wainwright’s Forecast for AVDL Q3 Earnings? - Defense World
What is Lifesci Capital’s Forecast for AVDL Q2 Earnings? - Defense World
Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
Sanctuary Advisors LLC Takes Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Rhumbline Advisers Increases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
What is Lifesci Capital’s Estimate for AVDL Q1 Earnings? - Defense World
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - The Manila Times
New York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Given “Buy” Rating at HC Wainwright - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call Transcript - MSN
Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating - Marketscreener.com
Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLC - Defense World
Avadel Pharmaceuticals Reports Strong Growth in 2024 - TipRanks
Oppenheimer maintains Avadel Outperform rating, $22 target By Investing.com - Investing.com UK
Earnings call transcript: Avadel Pharmaceuticals Q4 2024 reveals revenue miss - Investing.com India
Avadel Pharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
Avadel Pharmaceuticals PLC reports results for the quarter ended December 31Earnings Summary - TradingView
AVADEL PHARMACEUTICALS PLC SEC 10-K Report - TradingView
Avadel: Q4 Earnings Snapshot - CTPost
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Avadel Pharmaceuticals Reiterates 2025 Guidance -March 03, 2025 at 07:16 am EST - Marketscreener.com
Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey
Avadel Pharmaceuticals (AVDL) Expected to Announce Earnings on Monday - Defense World
Avadel Pharmaceuticals PLC expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.30%
4.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):